2020•New England Journal of MedicineRequires access

Comparing Apples to Apples for Fibroids

Elizabeth A. Stewart

Abstract

Hysterectomy remains the one-size-fits-all treatment for uterine fibroids.1 Despite the fact that more than 8000 women have participated in randomized clinical trials that compared uterine-artery embolization with surgery, only a few hundred of these women underwent myomectomy, the uterine-sparing alternative to hysterectomy.2,3 Data are needed to compare outcomes among uterine-sparing options for the treatment of fibroids, and the findings of the FEMME trial (A Randomized Trial of Treating Fibroids with Either Embolisation or Myomectomy to Measure the Effect on Quality of Life Among Women Wishing to Avoid Hysterectomy), reported in this issue of the Journal,4 further this effort. Hysterectomy has . . .

About this research paper

What this paper is about

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Hysterectomy, Uterine fibroids, Uterine artery embolization, Randomized controlled trial, Clinical trial, Leiomyoma, Quality of life (healthcare)